Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Notes underwriting agrmnt
Ayala Pharmaceuticals, Inc. (ADXS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/01/2023 8-K Quarterly results
01/30/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year  Interactive Data
01/25/2023 8-K Completion of Acquisition or Disposition of Assets, Departure of Directors or Certain Officers; Election of Directors; Appoin...
01/13/2023 8-K Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure  Interactive Data
01/12/2023 8-K Other Events  Interactive Data
12/02/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "ADVAXIS, INC. CERTIFICATE OF DESIGNATION OF SERIES E PREFERRED STOCK Pursuant to Section 151 of the General Corporation Law of the State of Delaware THE UNDERSIGNED DOES HEREBY CERTIFY, on behalf of Advaxis, Inc., a Delaware corporation , that the following resolution was duly adopted by the board of directors of the Corporation , in accordance with the provisions of Section 151 of the General Corporation Law of the State of Delaware, as amended on November 16, 2022, which resolution provides for the creation of a series of the Corporation’ s Preferred Stock, par value $0.001 per share, which is designated as “Series E Preferred Stock,” with the rights, preferences, privileges and restrictions set forth therein. WHEREAS, the Amended and Restated Certificate of Incorporation of the Corporat...",
"SECURITIES PURCHASE AGREEMENT"
10/19/2022 8-K Quarterly results
07/01/2022 8-K Quarterly results
06/24/2022 8-K Quarterly results
06/06/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
05/02/2022 8-K Quarterly results
04/07/2022 8-K Other Events  Interactive Data
04/01/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
02/01/2022 8-K Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Amendments to Articles of Inco...
01/28/2022 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Amendments to Articles of I...
Docs: "ADVAXIS, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES D CONVERTIBLE REDEEMABLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE GENERAL CORPORATION LAW OF THE STATE OF delaware The undersigned, Kenneth Berlin, does hereby certify that: 1. He is the President & Chief Executive Officer of Advaxis, Inc., a Delaware corporation . 2. The Corporation is authorized to issue 5,000,000 shares of preferred stock, none of which have been issued. 3. The following resolutions were duly adopted by the board of directors of the Corporation : WHEREAS, the Amended and Restated Certificate of Incorporation of the Corporation , provides for a class of its authorized stock known as preferred stock, consisting of 5,000,000 shares, $0.001 par value per share, issuable from time...",
"AMENDMENT NO. 2 TO THE SECOND AMENDED AND RESTATED BY-LAWS OF ADVAXIS, INC.",
"SECURITIES PURCHASE AGREEMENT"
12/30/2021 8-K Termination of a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "VIA EMAIL AND COURIER"
12/22/2021 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
Docs: "Advaxis Announces Acceptance for Trading on the OTCQX MONMOUTH JUNCTION, N.J., December 22, 2021 — Advaxis, Inc. , a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced that the Company has satisfied the requirements for trading of the Company’ s common stock on the OTCQX® Best Market and will begin trading on OTCQX at the open of the market on December 23, 2021 under the symbol ADXS. The Company previously traded on Nasdaq. OTCQX is the top tier of three markets organized by OTC Markets Group Inc. for trading over-the-counter securities, and is designed for established, investor-focused U.S. and international companies. To qualify for the OTCQX market, companies must meet high financial standards, follow best pra..."
12/17/2021 8-K Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibit...
Docs: "[email protected]"
12/15/2021 8-K Quarterly results
12/07/2021 8-K Quarterly results
11/22/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "How to Vote To vote, or if you have already voted and would like to change your vote, or if you have any questions or need assistance voting your shares, please call the firm assisting us with the solicitation of proxies: Kingsdale Advisors 1-888-518-1560 [email protected]"
11/17/2021 8-K Submission of Matters to a Vote of Security Holders, Other Events  Interactive Data
11/09/2021 8-K Acquisition/merger/asset purchase announced
Docs: "SECURITIES PURCHASE AGREEMENT",
"Plan of Distribution We are registering the shares of common stock previously issued to permit the resale of these shares of the common stock by the holders thereof from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale by the selling stockholders of shares of the common stock. We will bear all fees and expenses incident to our obligation to register the shares of the common stock, except that, if the shares of the common stock are sold through underwriters or broker-dealers, the selling stockholders will be responsible for underwriting discounts or commissions or agent’ s commissions. The selling stockholders may sell all or a portion of the shares of common stock beneficially owned by them and offered hereby from time to time directly o..."
11/08/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
09/20/2021 8-K Quarterly results
09/10/2021 8-K Quarterly results
Docs: "ADVAXIS, INC. CONDENSED BALANCE SHEETS July 31, 2021 October 31, 2020 ASSETS Current Assets: Cash and cash equivalents $ 45,257 $ 25,178 Deferred expenses 1,047 1,808 Prepaid expenses and other current assets 1,138 865 Total current assets 47,442 27,851 Property and equipment 278 2,393 Intangible assets 3,291 3,261 Operating right-of-use asset - 4,839 Other assets 11 182 Total assets $ 51,022 $ 38,526 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 454 $ 410 Accrued expenses 2,206 1,737 Common stock warrant liability 4,085 17 Current portion of operating lease liability - 962 Deferred revenue - 165 Total current liabilities 6,745 3,291 Operating lease liability, net of current portion - 5,055 Total liabilities 6,745 8,346 Commitments and contingencies – Note 9 ..."
08/11/2021 8-K Quarterly results
07/06/2021 8-K Quarterly results
07/02/2021 8-K Quarterly results
06/25/2021 8-K Quarterly results
06/21/2021 8-K Quarterly results
06/14/2021 8-K Quarterly results
06/04/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy